Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97 | Gaceta Mexicana de Oncologia | journal | 0.103 Q4 | 7 | 51 | 131 | 1106 | 11 | 121 | 0.07 | 21.69 | 42.78 | |
96 | Cancer Treatment and Research | journal | 0.131 Q4 | 65 | 26 | 101 | 1917 | 243 | 1 | 0.74 | 73.73 | 0.00 | |
95 | South Asian Journal of Cancer | journal | 0.131 Q4 | 25 | 55 | 185 | 1044 | 134 | 149 | 0.57 | 18.98 | 33.58 | |
94 | Atlas of Genetics and Cytogenetics in Oncology and Haematology | journal | 0.132 Q4 | 4 | 0 | 171 | 0 | 44 | 171 | 0.41 | 0.00 | 0.00 | |
93 | International Journal of Cancer Management | journal | 0.218 Q4 | 26 | 74 | 252 | 2342 | 204 | 246 | 0.72 | 31.65 | 47.91 | |
92 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.285 Q4 | 56 | 371 | 1334 | 17903 | 2072 | 693 | 1.82 | 48.26 | 43.90 | |
91 | Breast Disease | journal | 0.304 Q4 | 36 | 71 | 94 | 1921 | 117 | 94 | 1.38 | 27.06 | 46.21 | |
90 | Bulletin du Cancer | journal | 0.336 Q4 | 44 | 178 | 590 | 5172 | 569 | 438 | 0.87 | 29.06 | 49.86 | |
89 | Journal of B.U.ON. | journal | 0.352 Q4 | 37 | 0 | 1250 | 0 | 1716 | 1099 | 1.10 | 0.00 | 0.00 | |
88 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 19 | 156 | 605 | 5238 | 915 | 604 | 1.29 | 33.58 | 26.80 | |
87 | Molecular and Cellular Oncology | journal | 0.436 Q4 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | 54.55 | |
86 | Tumori | journal | 0.443 Q4 | 59 | 84 | 305 | 2741 | 498 | 279 | 1.69 | 32.63 | 50.33 | |
85 | Oncology Research and Treatment | journal | 0.495 Q4 | 55 | 95 | 301 | 2660 | 522 | 276 | 1.65 | 28.00 | 39.88 | |
84 | Cancer Reports | journal | 0.513 Q4 | 18 | 241 | 245 | 8110 | 509 | 239 | 2.06 | 33.65 | 39.62 | |
83 | Discover Oncology | journal | 0.514 Q4 | 44 | 142 | 107 | 7354 | 277 | 103 | 2.24 | 51.79 | 43.01 | |
82 | In Vivo | journal | 0.540 Q3 | 72 | 378 | 1239 | 12438 | 2990 | 1239 | 2.39 | 32.90 | 30.57 | |
81 | European Journal of Cancer, Supplement | journal | 0.571 Q3 | 29 | 0 | 14 | 0 | 29 | 13 | 2.07 | 0.00 | 0.00 | |
80 | Infectious Agents and Cancer | journal | 0.583 Q3 | 47 | 61 | 186 | 3193 | 683 | 182 | 3.58 | 52.34 | 44.08 | |
79 | International Journal of Biological Markers | journal | 0.587 Q3 | 47 | 46 | 137 | 1731 | 375 | 135 | 2.16 | 37.63 | 48.16 | |
78 | Anticancer Research | journal | 0.591 Q3 | 136 | 677 | 2375 | 22754 | 5416 | 2373 | 2.07 | 33.61 | 25.78 | |
77 | Cancer Biomarkers | journal | 0.622 Q3 | 54 | 137 | 424 | 5612 | 1285 | 424 | 2.83 | 40.96 | 40.79 | |
76 | Pathology and Oncology Research | journal | 0.640 Q3 | 61 | 140 | 694 | 5769 | 1759 | 640 | 2.63 | 41.21 | 42.66 | |
75 | Oncology Letters | journal | 0.657 Q3 | 81 | 460 | 3487 | 21237 | 10354 | 3486 | 2.81 | 46.17 | 36.61 | |
74 | Cancer Genomics and Proteomics | journal | 0.660 Q3 | 50 | 61 | 190 | 3820 | 526 | 190 | 2.62 | 62.62 | 41.63 | |
73 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 159 | 473 | 6498 | 1111 | 470 | 1.93 | 40.87 | 43.84 | |
72 | Leukemia Research | journal | 0.673 Q3 | 96 | 122 | 430 | 4247 | 774 | 293 | 1.76 | 34.81 | 45.67 | |
71 | Cancer Treatment and Research Communications | journal | 0.674 Q3 | 23 | 152 | 357 | 6582 | 933 | 338 | 2.57 | 43.30 | 44.63 | |
70 | Journal of Oral Pathology and Medicine | journal | 0.682 Q3 | 95 | 109 | 400 | 3478 | 1535 | 382 | 3.35 | 31.91 | 39.34 | |
69 | Molecular Medicine Reports | journal | 0.711 Q3 | 86 | 363 | 2816 | 16713 | 9976 | 2816 | 3.36 | 46.04 | 43.30 | |
68 | Differentiation | journal | 0.728 Q3 | 107 | 29 | 104 | 2151 | 309 | 101 | 2.42 | 74.17 | 42.07 | |
67 | FASEB BioAdvances | journal | 0.731 Q3 | 18 | 59 | 209 | 3156 | 593 | 201 | 2.86 | 53.49 | 42.07 | |
66 | Japanese Journal of Clinical Oncology | journal | 0.743 Q3 | 95 | 202 | 669 | 5293 | 1628 | 595 | 2.05 | 26.20 | 18.90 | |
65 | International Journal of Hyperthermia | journal | 0.762 Q3 | 98 | 160 | 561 | 6613 | 1969 | 541 | 3.07 | 41.33 | 37.38 | |
64 | Human Cell | journal | 0.773 Q3 | 44 | 164 | 372 | 7423 | 1465 | 347 | 3.95 | 45.26 | 38.90 | |
63 | Epigenomics | journal | 0.809 Q3 | 77 | 125 | 429 | 6934 | 1467 | 401 | 3.09 | 55.47 | 45.35 | |
62 | Cancer Chemotherapy and Pharmacology | journal | 0.811 Q3 | 122 | 129 | 624 | 4183 | 1952 | 614 | 2.94 | 32.43 | 42.91 | |
61 | Clinical and Translational Oncology | journal | 0.831 Q3 | 61 | 224 | 725 | 11618 | 2455 | 695 | 3.40 | 51.87 | 45.80 | |
60 | Leukemia and Lymphoma | journal | 0.837 Q3 | 102 | 475 | 1552 | 13932 | 2581 | 938 | 1.65 | 29.33 | 43.14 | |
59 | Oncology Reports | journal | 0.837 Q3 | 115 | 210 | 1364 | 8984 | 5346 | 1364 | 3.89 | 42.78 | 36.04 | |
58 | Oncology | journal | 0.856 Q3 | 107 | 65 | 291 | 1788 | 940 | 285 | 3.28 | 27.51 | 26.43 | |
57 | Oncology Reviews | journal | 0.861 Q3 | 31 | 9 | 64 | 717 | 235 | 63 | 3.05 | 79.67 | 50.00 | |
56 | Future Oncology | journal | 0.874 Q2 | 90 | 404 | 1149 | 16286 | 3380 | 1078 | 2.88 | 40.31 | 40.62 | |
55 | Cancer Causes and Control | journal | 1.008 Q2 | 147 | 133 | 384 | 5922 | 998 | 371 | 2.25 | 44.53 | 55.93 | |
54 | Cancer Microenvironment | journal | 1.010 Q2 | 51 | 0 | 16 | 0 | 77 | 15 | 0.00 | 0.00 | 0.00 | |
53 | Journal of Cancer Research and Clinical Oncology | journal | 1.017 Q2 | 109 | 304 | 923 | 12788 | 3834 | 892 | 3.81 | 42.07 | 39.12 | |
52 | Familial Cancer | journal | 1.031 Q2 | 67 | 53 | 149 | 1712 | 406 | 143 | 2.33 | 32.30 | 60.09 | |
51 | Virus Research | journal | 1.034 Q2 | 144 | 228 | 772 | 11910 | 3814 | 767 | 5.44 | 52.24 | 43.42 | |
50 | Hematological Oncology | journal | 1.051 Q2 | 54 | 124 | 339 | 4189 | 963 | 265 | 2.22 | 33.78 | 44.70 | |
49 | Carcinogenesis | journal | 1.071 Q2 | 223 | 116 | 489 | 5290 | 2001 | 473 | 4.46 | 45.60 | 42.05 | |
48 | Tumour Virus Research | journal | 1.097 Q2 | 34 | 17 | 88 | 1497 | 394 | 83 | 3.69 | 88.06 | 53.39 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®